Gates Foundation CEO says polio's return to Nigeria is her 'biggest disappointment'
Summary
Nigeria had recently accounted for more than half of the world’s polio cases, but was declared “polio-free” in 2015 by the World Health Organization.
Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, has said that her “biggest disappointment” since joining the foundation in 2014 was witnessing the re-emergence of polio in Nigeria after it had previously been thought to be eradicated from the African continent.
In August, the Nigerian federal government reported that two children had been paralyzed by polio, after more than two years without a reported case of wild poliovirus in the country. That prompted a renewed emergency outbreak response in the country. Nigeria had recently accounted for more than half of the world’s polio cases, but was declared “polio-free” in 2015 by the World Health Organization.
Speaking late in November at the American Enterprise Institute, a conservative think tank in Washington, D.C., Desmond-Hellmann said: “The world had happily gone two years polio-free in the entire continent of Africa ... and when these two cases were reported in Nigeria it was a big setback.”
So far in 2016, 33 cases of wild poliovirus have been reported, most of them in Afghanistan and Pakistan.
The experience taught the foundation to be more sceptical of apparent success, according to its CEO who offered health policy advice for the in-coming Administration of Donald Trump in the United States. “My number one thing that I would want president-elect Trump to remember is that a health crisis anywhere is a health crisis everywhere,” the Gates CEO said.
Related
-
Access Bank galvanizes efforts to combat HIV/AIDS epidemic in Nigeria
There is still so much to do to fast-track our response as leaders in various business sectors in the fight against ...
-
Access Bank sustains support for HIV/AIDs, NTDs interventions during Lagos marathon
Participants at the Access Bank's week-long Marathon Expo were also educated on NTDs, which also constitute a major public ...
-
Ebola vaccine induces immune response in new trial
The vaccine induced an immune response that persisted for approximately one year in healthy adult volunteers.
Sustainable Development Section Sponsor
Most Popular
- Low-tech longevity investments could unlock $6 trillion worldwide – WEF
- Why is Europe’s economy falling short? Part 1
- IFC launches $2bn green bond as investor demand surges to record levels
- Afreximbank President visits African Medical Centre of Excellence, Abuja
- Farmers worldwide report income strain and climate losses – survey
- Cocoa value-addition push as new test for Nigeria’s industrial ambition
- Africa’s bid to capture more mineral value



